Chadli Dziri

Prof. Chadli Dziri

Surgical Department, Medical Faculty of Tunis, Tunis El Manar University, Tunisia, Tunis, Tunisia
orcid
Prof. Emeritus - General Surgery

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2020 in Parasite
Verified
Journal Article
Open access
PDF file
DVDominique A. Vuitton
Dominique A. Vuitton
Donald McManusDonald McManus
Donald McManus
MRMichael T. Rogan
Michael T. Rogan
TRThomas Romig
Thomas Romig
BGBruno Gottstein
Bruno Gottstein
GMGeorges A. Mantion
Georges A. Mantion
Echinococcoses require the involvement of specialists from nearly all disciplines; standardization of the terminology used in the field is thus crucial. To harmonize echinococcosis terminology on sound scientific and linguistic grounds, the World Association of Echinococcosis launched a Formal Consensus process. Under the coordination of a Steering and Writing Group (SWG), a Consultation and Rating Group (CRG) had the main missions of (1) providing input on the list of terms drafted by the SWG, taking into account the available literature and the participants’ experience; and (2) providing independent rating on all debated terms submitted to vote. The mission of the Reading and Review Group (RRG) was to give an opinion about the recommendation paper in terms of readability, acceptability and applicability. The main achievements of this process were: (1) an update of the current nomenclature of Echinococcus spp.; (2) an agreement on three names of diseases due to Echinococcus spp.: Cystic Echinococcosis (CE), Alveolar Echinococcosis (AE) and Neotropical Echinococcosis (NE), and the exclusion of all other names; (3) an agreement on the restricted use of the adjective “hydatid” to refer to the cyst and fluid due to E. granulosus sensu lato; and (4) an agreement on a standardized description of the surgical operations for CE, according to the “Approach, cyst Opening, Resection, and Completeness” (AORC) framework. In addition, 95 “approved” and 60 “rejected” terms were listed. The recommendations provided in this paper will be applicable to scientific publications in English and communication with professionals. They will be used for translation into other languages spoken in endemic countries.

3 August 2004 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CDChadli Dziri
Chadli Dziri
KHKarim Haouet
Karim Haouet
AFAbe Fingerhut
Abe Fingerhut

7 April 2009 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CDChadli Dziri
Chadli Dziri
KHKarim Haouet
Karim Haouet
AFAbe Fingerhut
Abe Fingerhut
AZAbdeljelil Zaouche
Abdeljelil Zaouche

27 July 2013 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
AFA. Fingerhut
A. Fingerhut
CDChadli Dziri
Chadli Dziri
OGO. J. Garden
O. J. Garden
DGD. Gouma
D. Gouma
BMB. Millat
B. Millat
ETE. Targarona
E. Targarona

26 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JVJulie Veziant
Julie Veziant
MBMathilde Bonnet
Mathilde Bonnet
BOBob-Valéry Occéan
Bob-Valéry Occéan
CDChadli Dziri
Chadli Dziri
Bruno PereiraBruno Pereira
Bruno Pereira
SKSlim Karem
Slim Karem
Aim: The aims of this systematic review and meta-analysis were to assess to what extent probiotics/synbiotics reduce infectious complications after colorectal surgery and whether probiotics or synbiotics should be considered as perioperative measures preventing or reducing infectious complications after CRS and should be included in enhanced recovery programmes (ERP). Secondary aims were to answer practical questions precisely on the best formulation and the type and timing of probiotics or synbiotics in CRS. Method: This systematic review and quantitative meta-analysis were conducted in accordance with PRISMA 2020 guidelines. Inclusion criteria were randomised trials comparing perioperative probiotics/synbiotics with a placebo or standard care in elective colorectal surgery. Exclusion criteria were non-randomised trials. Overall infectious complications and surgical site infections (SSIs including both deep abdominal infections and wound (skin or under the skin) infections) were the primary outcomes. Secondary outcomes were pulmonary and urinary infections, wound infections, and anastomotic leaks. The databases consulted were Medline, Cochrane Database of Systematic Reviews, Scopus, and Clinical Trials Register. Risk of bias was assessed according to the GRADE approach. The analysis calculated the random effects estimates risk ratio (RR) for each outcome. Results: 21 trials were included; 15 evaluated probiotics, and 6 evaluated synbiotics. There were significantly fewer infectious complications (risk ratio (RR) 0.59 [0.47–0.75], I2 = 15%) and fewer SSI (RR 0.70 [0.52–0.95], I2 = 0%) in the probiotic or synbiotic group. There were also significantly fewer pulmonary infections (RR 0.35 [0.20–0.63]) and urinary infections RR 0.41 [0.19–0.87]) as opposed to anastomotic leaks (RR 0.83 [0.47–1.48]) and wound infections (RR 0.74 [0.53–1.03]). Sensitivity analyses showed no significant difference between probiotics and synbiotics in reducing postoperative infections (RR 0.55 [0.42–0.73] versus RR 0.69 [0.42–1.13], p = 0.46). Conclusions: Based on the finding of this study, probiotics/synbiotics reduce infectious complications after colorectal surgery. The effect size was more pronounced for pulmonary and urinary infections. From a practical aspect, some of the questions related to formulations and duration of probiotics or synbiotics need to be answered before including them definitively in enhanced recovery after colorectal surgery programmes.